Also trades as: SZLS.TO (TSX) · $vol 0M
SZLSF OTC
StageZero Life Sciences Ltd.
1W: +0.0%
1M: +0.0%
3M: -80.4%
YTD: +100.0%
1Y: -80.4%
3Y: -97.8%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$4M
-25.1% ▼
5Y CAGR: +55.9%
Gross Profit
-$404K
-134.3% ▼
Operating Income
-$8M
+2.7% ▲
Net Income
-$11M
-52.5% ▼
EPS (Diluted)
$-0.11
-10.0% ▼
EBITDA
-$10M
-80.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $186K | $139K | $4M | $5M | $4M |
| YoY Growth | -54.8% | -25.4% | +2893.3% | +22.1% | -25.1% |
| Cost of Revenue | $1M | $1M | $3M | $4M | $4M |
| Gross Profit | -$1M | -$961K | $696K | $1M | -$404K |
| Gross Margin | -580.7% | -692.8% | 16.8% | 23.2% | -10.6% |
| R&D Expenses | $0 | $0 | $219K | $775K | $352K |
| SG&A Expenses | $3M | $4M | $4M | $8M | $7M |
| Operating Expenses | $3M | $4M | $4M | $9M | $7M |
| Operating Income | -$4M | -$5M | -$4M | -$8M | -$8M |
| Operating Margin | -2343.0% | -3686.2% | -90.0% | -157.1% | -204.1% |
| Interest Expense | $1M | $803K | $699K | $200K | $284K |
| Income Before Tax | -$4M | -$3M | -$7M | -$7M | -$11M |
| Tax Expense | $1M | $830K | $0 | $0 | $0 |
| Net Income | -$4M | -$3M | -$7M | -$7M | -$11M |
| Net Margin | -2121.8% | -2510.2% | -165.3% | -147.7% | -300.8% |
| EPS (Diluted) | $-0.23 | $-0.16 | $-0.15 | $-0.10 | $-0.11 |
| EBITDA | -$3M | -$2M | -$6M | -$6M | -$10M |
| Shares Outstanding | 17M | 26M | 45M | 71M | 99M |